In this week’s video, Dr. Brian G.M. Durie discusses how immune therapies work in the treatment of myeloma.

The BOTTOM LINE: 

Best bets to fight high-risk myeloma are therapies that replace, rather than manipulate, the immune system. 

Previous Post
How common are low platelet counts after autologous stem cell transplant?
Next Post
Do all myeloma patients become high-risk at some point?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.